GSK readies for pivotal ruling in Zantac cases
Published
Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value
Full ArticlePublished
Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value
Full Article